MicroMGx

MicroMGx

Early Stage

Discovery platform to identify hundreds of new compounds

Discovery platform to identify hundreds of new compounds

Overview

Raised to Date: Raised: $124,508

Total Commitments ($USD)

Platform

Netcapital

Start Date

09/04/2022

Close Date

04/21/2023

Min. Goal
$10,001
Max. Goal
$1,069,998
Min. Investment

$100

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.37

Pre-Money Valuation

$10,976,063

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/29/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$546

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2015

Industry

Business Services, Software, & Applications

Tech Sector

Biotech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Location

Chicago, Illinois

Business Type

Growth

MicroMGx, with a valuation of $10.9 million, is raising funds on NetCapital. The company has developed a discovery platform that helps in discovering new chemistry and compounds produced by microbes. The newly discovered compounds can be used by life sciences companies to make economically-valuable and environment-friendly products for agriculture, pharmaceuticals, and other industries. MicroMGx has discovered new molecules for clients in the agriculture and animal health industries and has a self-built library of over 2,500 isolated microbial strains. William Metcalf, Neil L. Kelleher, and Regan Thomson founded MicroMGx in July 2015. The current crowdfunding campaign has a minimum target of $10,001 and a maximum target of $1,069,998. The campaign proceeds will be used for compensation, platform costs, testing MGX 1001, rent, structure isolation, and additional equipment.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$523,700

$537,000

COGS

$731,195

$724,353

Tax

$0

$0

 

 

Net Income

$-134,068

$-269,672

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$85,011

$203,237

Accounts Receivable

$0

$0

Total Assets

$208,505

$221,539

Short-Term Debt

$86,000

$0

Long-Term Debt

$160,300

$117,200

Total Liabilities

$246,300

$117,200

Financials as of: 09/04/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
MicroMGx on NetCapital 2022
Platform: Netcapital
Security Type: Equity - Common
Valuation: $10,976,063
Price per Share: $2.37

Follow company

Follow MicroMGx on NetCapital 2022

Buy MicroMGx's Deal Report

Warning: according to the close date for this deal, MicroMGx may no longer be accepting investments.

MicroMGx Deal Report

Get KingsCrowd’s comprehensive report on MicroMGx including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether MicroMGx is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the MicroMGx deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge